Challenges in organizing effective oncology service: Inter-European variability in the example of head and neck cancers

European Archives of Oto-Rhino-Laryngology

Volumn 271, Issue 9, 2014, Pages 2343-2347

  Malicki, Julian ^a,b   Golusinski, Wojciech ^a,b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b GREATER POLAND CANCER CENTRE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CENTER; ETHNIC GROUP; EUROPE; EUROPEAN UNION; HEAD AND NECK TUMOR; HUMAN; NEOPLASMS; ONCOLOGY; ORGANIZATION AND MANAGEMENT; POLAND; SOCIOECONOMICS; SQUAMOUS CELL CARCINOMA; STANDARDS;

CANCER CARE FACILITIES; CARCINOMA, SQUAMOUS CELL; ETHNIC GROUPS; EUROPE; EUROPEAN UNION; HEAD AND NECK NEOPLASMS; HUMANS; MEDICAL ONCOLOGY; NEOPLASMS; POLAND; SOCIOECONOMIC FACTORS;

EID: 84905906005     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-014-3197-x     Document Type: Review

References (58)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69-90
2. Petera J, Dušek L (2013) Cancer in the elderly. Rep Pract Oncol Radiother 18:1-5
3. Coleman MP, Quaresma M, Berrino F, Lutz J-M, De Angelis R, Capocaccia R et al (2008) Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9:730-756
4. Boyle P, Levin B (2008) World Cancer Report. WHO International Agency for Research on Cancer, Lyon
5. Petersen PE (2009) Oral cancer prevention and control - the approach of the World Health Organization. Oral Oncol 45:454-460
6. Verdecchia A, Santaquilani M, Sant M (2009) Survival for cancer patients in Europe. Ann Ist Super Sanita 45:315-324
7. Ramos A, Torrecilla JL, Lara P, Herruzo I, Contreras J, Manas A et al (2012) Should the prescription of oral anticancer drugs be restricted? Rep Pract Oncol Radiother 17:187-189
8. WHO (2007) Cancer control: knowledge into action: WHO guide for effective programmes. World Health Organization
9. Thwaites DI, Malicki J (2011) Physics and technology in ESTRO and in radiotherapy and oncology: past, present and into the 4th dimension. Radiother Oncol 100:327-332
10. Drummond MF, Mason AR (2007) European perspective on the costs and cost-effectiveness of cancer therapies. J Clin Oncol 25:191-195
11. Ciric E, Sersa G (2010) Radiotherapy in combination with vascular-targeted therapies. Radiol Oncol 44:67-78
12. Prijic S, Sersa G (2011) Magnetic nanoparticles as targeted delivery systems in oncology. Radiol Oncol 45:1-16
13. Prijic S, Prosen L, Cemazar M, Scancar J, Romih R, Lavrencak J et al (2012) Surface modified magnetic nanoparticles for immuno-gene therapy of murine mammary adenocarcinoma. Biomaterials 33:4379-4391
14. Flitcroft K, Gillespie J, Salkeld G, Carter S, Trevena L (2011) Getting evidence into policy: the need for deliberative strategies? Soc Sci Med 72:1039-1046
15. Mumme A, Laban S, Knecht R (2012) New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011. Eur Arch Otorhinolaryngol 269:2303-2308
16. Gomez-Millan J, Fernández JR, Medina Carmona JA (2013) Current status of IMRT in head and neck cancer. Rep Pract Oncol Radiother 18:371-375
17. Donaldson M. Engineering tools and methods in the delivery of cancer care services. http://www.ncbi.nlm.nih.gov/books/NBK22828/. Accessed 30 May 2014
18. Otter R, Qiao Y-L, Burton R, Samiei M, Parkin M, Trapido E et al (2009) Organization of population-based cancer control programs: Europe and the world. Tumori 95:623-636
19. Van Doorslaer E, Wagstaff A, van der Burg H, Christiansen T, De Graeve D, Duchesne I et al (2000) Equity in the delivery of health care in Europe and the US. J Health Econ 19:553-583
20. Pyenson BS, Sander MS, Jiang Y, Kahn H, Mulshine JL (2012) An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff 31:770-779
21. Kessler R, Glasgow RE (2011) A proposal to speed translation of healthcare research into practice: dramatic change is needed. Am J Prev Med 40:637-644
22. Colditz GA, Wolin KY, Gehlert S (2012) Applying what we know to accelerate cancer prevention. Sci Transl Med 4:127
23. Ries LA, Harkins D, Krapcho M et al (2006) SEER cancer statistics review, 1975-2003. National Cancer Institute, Bethesda
24. Bray F, Sankila R, Ferlay J, Parkin DM (2002) Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 38:99-166
25. Wojtyś P, Godlewski D, Antczak A (2013) Predictions of cancer incidence in Poland in 2019. Central Eur J Med 8(2):185-191
26. Čarman J, Strojan P (2012) Nasopharyngeal carcinoma in Slovenia, 1990-2003 (results of treatment with conventional two-dimensional radiotherapy). Rep Pract Oncol Radiother 17:71-78
27. Reinfuss M, Byrski E, Malicki J (2013) Radiotherapy facilities, equipment, and staffing in Poland: 2005-2011. Rep Pract Oncol Radiother 18:159-172
28. Lievens Y, Grau C (2012) Health economics in radiation oncology: introducing the ESTRO HERO project. Radiother Oncol 103:109-112
29. Grau CC, Defourny N, Malicki J, Dunscombe P (2014) Radiotherapy departments and equipment in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol
30. Corbex M, Burton R, Sancho-Garnier H (2012) Breast cancer early detection methods for low and middle income countries, a review of the evidence. Breast 21:428-434
31. Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W et al (2003) European health systems and cancer care. Ann Oncol 14(Suppl 5):v41-v60
32. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H et al (2013) Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 49:1374-1403
33. Krystyna S-W, Rucinski P (2008) The main challenges of polish oncology. Public Health Rep 123:655-663
34. Dyzmann-Sroka A, Harska A, Myslinska W, Olenderczyk W, Rymarczyk-Wciorko M, Szczȩch B et al (2008) Cancer incidence and mortality in Greater Poland Province in 2006 - report. Rep Pract Oncol Radiother 13:287-299
35. Malicki J, Dyzmann-Sroka A (2013) Cancer incidence in the Greater Poland Region-analysis of the year 2010. Rep Pract Oncol Radiother (accepted)
36. Dyzmann-Sroka A, Roszak A (2012) Methods of raising data quality of cancer registries. Zesz Nauk WCO 9(4):163-168
37. Verdecchia A, Baili P, Quaglia A, Kunkler I, Ciampichini R, Berrino F et al (2008) Patient survival for all cancers combined as indicator of cancer control in Europe. Eur J Public Health 18:527-532
38. Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359:1143-1154
39. Trojanowska A (2011) Squamous cell carcinoma of the head and neck - the role of diffusion and perfusion imaging in tumor recurrence and follow-up. Rep Pract Oncol Radiother 16:203-208
40. Wojciechowska U, Didkowska J, Zatoński W (2012) Cancer in Poland in 2010, Warsaw
41. Majchrzak E, Szybiak B, Wegner A, Pienkowski P, Pazdrowski J, Luczewski L et al (2014) Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature. Radiol Oncol 48:1-10
42. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709-720
43. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24-35
44. Ilmarinen T, Auvinen E, Hiltunen-Back E, Ranki A, Aaltonen L-M, Pitkäranta A (2012) Transmission of human papillomavirus DNA from patient to surgical masks, gloves and oral mucosa of medical personnel during treatment of laryngeal papillomas and genital warts. Eur Arch Otorhinolaryngol 269:2367-2371
45. Cieślak K, Pawlukiewicz M, Goła̧b D, Konys M, Kuśnierkiewicz M, Kleka P (2013) Styles of coping with stress of cancer in patients treated with radiotherapy and expectations towards medical staff - practical implications. Rep Pract Oncol Radiother 18:61-66
46. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371:1695-1709
47. Van der Molen L, van Rossum M, Burkhead L, Smeele L, Hilgers F (2009) Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol 266:889-900
48. Dos Santos LV, Carvalho AL (2011) Bcl-2 targeted-therapy for the treatment of head and neck squamous cell carcinoma. Recent Patents Anticancer Drug Discov 6:45-57
49. Torrente S, Turri L, Deantonio L, Cena T, Gambaro G, Magnani C et al (2012) Concomitant chemo-radiotherapy for unresectable oesophageal cancer: a mono-institutional study on 40 patients. Rep Pract Oncol Radiother 17:226-232
50. Malicki J (2012) The importance of accurate treatment planning, delivery, and dose verification. Rep Pract Oncol Radiother 17:63-65
51. Pawlicki T, Dunscombe P, Mundt A, Malicki J (2010) Staffing for quality: overview in quality and safety in radiotherapy. Taylor & Francis, New York
52. Grau C, Borras JM, Malicki J, Slotman B, Dunscombe P, Coffey M et al (2013) Radiotherapy capacity in Europe. Lancet Oncol 14:e196-e198
53. Sansom, Clare. Improving cancer care in Poland. http://ecancer.org/news/ 3045-improving-cancer-care-in-poland.php. Accessed 29 May 2014
54. Śmigielska M, Milecki P (2012) Investment in radiotherapy infrastructure positively affected the economic status of an oncology hospital. Rep Pract Oncol Radiother 17:151-156
55. Malicka A (2012) Analysis of a patient environment during stay in a hospital. Zesz Nauk Polit Pozn Arch Urban 28:81-96
56. Lievens Y, Defourny N, Coffey M, Borras J (2014) Radiotherapy staffing in the European countries: final results from the ESTROHERO survey. Radiother Oncol
57. LopezGuerra JL, Isa N, Kim MM, Bourgier C, Marsiglia H (2012) New perspectives in radiation oncology: Young radiation oncologist point of view and challenges. Rep Pract Oncol Radiother 17:251-254
58. Janaszczyk A, Bogusz-Czerniewicz M (2011) Comparison of curricula in radiation technology in the field of radiotherapy in selected European Union countries. Rep Pract Oncol Radiother 16:189-197